ALGBE — Global Bioenergies SA Share Price
0.000.00%
Last trade - 00:00- €33.42m
- €21.57m
- €3.25m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 12.03 | ||
| Price to Tang. Book | 13.64 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 10.29 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -351.22% | ||
| Return on Equity | -166.05% | ||
| Operating Margin | -306.25% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 0.12 | 0.06 | 0.1 | 0.7 | 3.25 | 10 | 6.75 | 36.25% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Global Bioenergies SA is a France-based company that specializes in the development of a process to produce isobutene biologically from renewable resources. Isobutene, a hydrocarbon, can be converted into fuels such as isooctane, as well as into various materials (synthetic rubber, organic glass, plastics). The process developed by Global Bioenergies SA is based on the design of an artificial metabolic pathway comprising several enzymes catalyzing reactions not observed in nature. Six patent applications have been filed by the Company. The first two applications covering the key steps of the bio-production of isobutene and other olefins have already been published. It distributes butane and propane containing bio-isobutene, in a e partnership with Global Bioenergies. It operates through Syngip.
Directors
- Corinne Granger CHM
- Marc Delcourt CEO (49)
- Samuel Dubruque CFO
- Richard Bockrath VPR
- Charles Nakamura VPR
- Bernard Chaud OTH
- Nicolas Cordier DRC
- Alain Fanet DRC
- Pierre Levi DRC (66)
- Pierre Monsan IND
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- August 25th, 2008
- Public Since
- June 9th, 2011
- No. of Employees
- 45
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Euronext - Paris
- Shares in Issue
- 18,161,627
- Address
- 5, rue Henri Desbrueres, EVRY, 91000
- Web
- https://www.global-bioenergies.com/
- Phone
- +33 164982050
- Contact
- Samuel Dubruque
- Auditors
- France Audit Consultants International
Upcoming Events for ALGBE
Similar to ALGBE
AbL Diagnostics SA
Euronext - Paris
Affluent Medical SAS
Euronext - Paris
Alpha MOS SA
Euronext - Paris
Amplitude Surgical SA
Euronext - Paris
Biomerieux SA
Euronext - Paris
FAQ
What is the Global Bioenergies SA share price?
As of Today at 19:09 UTC, shares in Global Bioenergies SA are trading at €1.84. This share price information is delayed by 15 minutes.
How has the Global Bioenergies SA share price performed this year?
Shares in Global Bioenergies SA last closed at €1.84 and the price had moved by -11.54% over the past 365 days. In terms of relative price strength the Global Bioenergies SA share price has underperformed the FTSE Global All Cap Index by -16.95% over the past year.
What are the analyst and broker recommendations for Global Bioenergies SA?
The overall consensus recommendation for Global Bioenergies SA is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Global Bioenergies SA dividend yield?
Global Bioenergies SA does not currently pay a dividend.
Does Global Bioenergies SA pay a dividend?
Global Bioenergies SA does not currently pay a dividend.
When does Global Bioenergies SA next pay dividends?
Global Bioenergies SA does not currently pay a dividend.
How do I buy Global Bioenergies SA shares?
To buy shares in Global Bioenergies SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Global Bioenergies SA?
As of the previous close price of €1.84, shares in Global Bioenergies SA had a market capitalisation of €33.42m.
Where are Global Bioenergies SA shares listed?
Here are the trading details for Global Bioenergies SA:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: ALGBE
What kind of share is Global Bioenergies SA?
Based on an overall assessment of its quality, value and momentum Global Bioenergies SA is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Global Bioenergies SA share price forecast for 2024?
The analyst consensus target price for shares in Global Bioenergies SA is €3.50. That is 90.22% above the last closing price of €1.84.
Analysts covering Global Bioenergies SA currently have a consensus Earnings Per Share (EPS) forecast of -€0.37 for the next financial year.
What is the trend in the Global Bioenergies SA share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Global Bioenergies SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -17.92%.
As of the last closing price of €1.84, shares in Global Bioenergies SA were trading -18.2% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Global Bioenergies SA PE Ratio?
The Global Bioenergies SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €1.84.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Global Bioenergies SA?
Global Bioenergies SA's management team is headed by:
- Corinne Granger - CHM
- Marc Delcourt - CEO
- Samuel Dubruque - CFO
- Richard Bockrath - VPR
- Charles Nakamura - VPR
- Bernard Chaud - OTH
- Nicolas Cordier - DRC
- Alain Fanet - DRC
- Pierre Levi - DRC
- Pierre Monsan - IND